DZ Bank
IONS icon

DZ Bank’s Ionis Pharmaceuticals IONS Stock Holding History

DZ Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
151,301
-16,356
-10% -$1.23M 0.01% 366
2026
Q1 		$12.6M Hold
167,657
– – 0.01% 349
2025
Q4 		$13.3M Buy
+167,657
New +$12.6M 0.01% 323
2018
Q2 		– Sell
-6,700
Closed -$295K – 959
2018
Q1 		$295K Buy
+6,700
New +$340K ﹤0.01% 871

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DZ Bank's IONS Position: Q2 2026 in Review

DZ Bank reduced its Ionis Pharmaceuticals (IONS) stake by 9.8% in Q2 2026, selling an estimated $1.23M and leaving 151,301 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #366.

DZ Bank first reported a position in IONS in Q1 2018 and has held it in 4 quarters since. The position peaked at $13.3M in Q4 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • DZ Bank held 151,301 shares of Ionis Pharmaceuticals worth $12M as of Q2 2026.
  • DZ Bank sold 16,356 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.23M.
  • Ionis Pharmaceuticals made up 0.01% of DZ Bank's portfolio in Q2 2026, its #366 holding.
  • DZ Bank first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 4 quarters since.
  • DZ Bank's Ionis Pharmaceuticals position peaked at $13.3M in Q4 2025.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.